The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Trimethoprim-Sulfamethoxazole Revisited
Abstract
During the past 3 decades, the combination of trimethoprim and sulfamethoxazole has occupied a central role in the treatment of various commonly encountered infections and has also been particularly useful for several specific clinical conditions. However, changing resistance patterns and the introduction of newer broad-spectrum antibiotics have led to the need to carefully redefine the appropriate use of this agent in clinical practice. While trimethoprim-sulfamethoxazole's traditional role as empirical therapy for several infections has been modified by increasing resistance, it remains a highly useful alternative to the new generation of expanded-spectrum agents if resistance patterns and other clinical variables are carefully considered. It also seems to have an increasing role as a cost-effective pathogen-directed therapy with the potential to decrease or delay development of resistance to newer antibiotics used for empirical treatment. In addition, trimethoprim-sulfamethoxazole continues to be the drug of choice for several clinical indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., & Stamm, W. E. (1999) · Clinical Infectious Diseases · doi:10.1086/520427 · Cited by 1,188
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
Management of Urinary Tract Infections in Adults
Desforges, J. F., Stamm, W. E., & Hooton, T. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291808 · Cited by 899
KOVACS, J. A., HIEMENZ, J. W., MACHER, A. M., STOVER, D., MURRAY, H. W., SHELHAMER, J., LANE, H. C., URMACHER, C., HONIG, C., LONGO, D. L., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-663 · Cited by 855
Stegeman, C. A., Cohen Tervaert, J. W., de Jong, P. E., & Kallenberg, C. G. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350103 · Cited by 777
Gupta, K., Hooton, T. M., & Stamm, W. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-1-200107030-00012 · Cited by 677
Niederman (1993) · Medical Entomology and Zoology · Cited by 624
Gupta, K. (1999) · JAMA · doi:10.1001/jama.281.8.736 · Cited by 609
(2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70002-4 · Cited by 607
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
Partnership, S. A. A. H. (2004) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2003.12.003 · Cited by 535
Manges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Self-citationTrimethoprim and sulfonamide resistance.
Huovinen, P., Sundström, L., Swedberg, G., & Sköld, O. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.279 · Cited by 523
Resistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
TRIMETHOPRIM, A SULPHONAMIDE POTENTIATOR
BUSHBY, S. R. M., & HITCHINGS, G. H. (1968) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1968.tb00475.x · Cited by 466
Gales, A. C., Jones, R. N., Forward, K. R., Liñares, J., Sader, H. S., & Verhoef, J. (2001) · Clinical Infectious Diseases · doi:10.1086/320183 · Cited by 441
Wiktor, S. Z., Sassan-Morokro, M., Grant, A. D., Abouya, L., Karon, J. M., Maurice, C., Djomand, G., Ackah, A., Domoua, K., Kadio, A., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03465-0 · Cited by 418
Anglaret, X., Chêne, G., Attia, A., Toure, S., Lafont, S., Combe, P., Manlan, K., N'Dri-Yoman, T., & Salamon, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07399-1 · Cited by 404
Hoban, D. J., Doern, G. V., Fluit, A. C., Roussel‐Delvallez, M., & Jones, R. N. (2001) · Clinical Infectious Diseases · doi:10.1086/320181 · Cited by 375
Trends in Antibiotic Resistance Among Diarrheal Pathogens Isolated in Thailand Over 15 Years
Hoge, C. W., Gambel, J. M., Srijan, A., Pitarangsi, C., & Echeverria, P. (1998) · Clinical Infectious Diseases · doi:10.1086/516303 · Cited by 375
Sattler, F. R., Cowan, R., Nielsen, D. M., & Ruskin, J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-280 · Cited by 360
Hardy, W. D., Feinberg, J., Finkelstein, D. M., Power, M. E., He, W., Kaczka, C., Frame, P. T., Holmes, M., Waskin, H., Fass, R. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272604 · Cited by 346
Whipple Disease: Clinical Review of 52 Cases
Durand, D. V., Lecomte, C., Cathébras, P., Rousset, H., & Godeau, P. (1997) · Medicine · doi:10.1097/00005792-199705000-00003 · Cited by 345
Medical Management of HIV Infection
Bartlett, J. G., Gallant, J. E., & Pham, P. A. (1996) · Medical Entomology and Zoology · Cited by 329
Medina, I., Mills, J., Leoung, G., Hopewell, P. C., Lee, B., Modin, G., Benowitz, N., & Wofsy, C. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231202 · Cited by 320
(1997) · PsycEXTRA Dataset · doi:10.1037/e547472006-001 · Cited by 305
Sahm, D. F., Thornsberry, C., Mayfield, D. C., Jones, M. E., & Karlowsky, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1402-1406.2001 · Cited by 294
Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-6-200103200-00013 · Cited by 251
Hughes, W. T., Feldman, S., Chaudhary, S. C., Ossi, M. J., Cox, F., & Sanyal, S. K. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80028-6 · Cited by 241
Carr, A., Tindall, B., Brew, B. J., Marriott, D. J., Harkness, J. L., Penny, R., & Cooper, D. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-106 · Cited by 232
Ackers, M.-L., Puhr, N. D., Tauxe, R. V., & Mintz, E. D. (2000) · JAMA · doi:10.1001/jama.283.20.2668 · Cited by 223
Renal Mechanism of Trimethoprim-induced Hyperkalemia
Velazquez, H., Perazella, M. A., Wright, F. S., & Ellison, D. H. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-4-199308150-00008 · Cited by 223
Effect of Trimethoprim-Sulfamethoxazole on the Renal Excretion of Creatinine in Man
Berglund, F., Killander, J., & Pompeius, R. (1975) · Journal of Urology · doi:10.1016/s0022-5347(17)67149-0 · Cited by 216
Trimethoprim-Sulfamethoxazole: In Vitro Microbiological Aspects
Bushby, S. R. M. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_3.s442 · Cited by 207
Prevention and Treatment of Traveler's Diarrhea
(1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292122 · Cited by 206
Safrin, S., Finkelstein, D. M., Feinberg, J., Frame, P., Simpson, G., Wu, A., Cheung, T., Soiero, R., Hojczyk, P., & Black, J. R. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-9-199605010-00003 · Cited by 205
A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens
Ioannidis, J. P. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440020081010 · Cited by 197
Adverse Reactions to Trimethoprim-Sulfamethoxazole in Hospitalized Patients
Jick, H. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.2.426 · Cited by 192
Zhanel, G. G., Karlowsky, J. A., Harding, G. K. M., Carrie, A., Mazzulli, T., Low, D. E., The Canadian Urinary Isolate Study Group, & Hoban, D. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1089-1092.2000 · Cited by 190
Kazanjian, P., Locke, A. B., Hossler, P. A., Lane, B. R., Bartlett, M. S., Smith, J. W., Cannon, M., & Meshnick, S. R. (1998) · AIDS · doi:10.1097/00002030-199808000-00009 · Cited by 171
Prevention of Infection Caused byPneumocystis cariniiin Transplant Recipients
Fishman, J. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323129 · Cited by 161
Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates
Wright, S. W., Wrenn, K. D., & Haynes, M. L. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.10128.x · Cited by 153
Resistance of Shigella, Salmonella, and Other Selected Enteric Pathogens to Antimicrobial Agents
Murray, B. E. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.supplement_2.s172 · Cited by 141
Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis
Egan, C. A., Grant, W. J., Morris, S. E., Saffle, J. R., & Zone, J. J. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70497-4 · Cited by 132
Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
Martin, J. N., Rose, D. A., Hadley, W. K., Perdreau‐Remington, F., Lam, P. K., & Gerberding, J. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/315132 · Cited by 126
Prostatitis and urinary tract infection in men: what’s new; what’s true?
Lipsky, B. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00017-0 · Cited by 125
Drug-Induced Disorders of Glucose Metabolism: Mechanisms and Management
Chan, J. C. N., Cockram, C. S., & Critchley, J. (1996) · Drug Safety · doi:10.2165/00002018-199615020-00005 · Cited by 117
Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients
Klein, N. C., Duncanson, F. P., Lenox, T. H., Forszpaniak, C., Sherer, C., Quentzel, H., Nunez, M., Suarez, M., Kawwaff, O., Pitta, A., et al. (1992) · AIDS · doi:10.1097/00002030-199203000-00007 · Cited by 114
Williams, J. W. (1995) · JAMA · doi:10.1001/jama.1995.03520370057037 · Cited by 113
O’Reilly, R. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020106 · Cited by 108
Clinical Experience with Adverse Reactions to Trimethoprim-Sulfamethoxazole
Frisch, J. M. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_3.s607 · Cited by 97
Drugs Five Years Later: Trimethoprim-Sulfamethoxazole in the United States
Wormser, G. P., & Keusch, G. T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-3-420 · Cited by 96
Jick, H., & Derby, L. E. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04378.x · Cited by 83
Factors associated with trimethoprim-resistant bacteria isolated from urine samples
Steinke, D. T., Seaton, R. A., Phillips, G., MacDonald, T. M., & Davey, P. G. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.6.841 · Cited by 69
The Effect of Different Sulfonamides on Phenytoin Metabolism in Man
Hansen, J. M., Kampmann, J. P., Siersbæk‐Nielsen, K., Lumholtz, I. B., Arrøe, M., Abildgaard, U., & Skovsted, L. (1979) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1979.tb00729.x · Cited by 69
Toma, E., Thorne, A., Singer, J., Raboud, J., Lemieux, C., Trottier, S., Bergeron, M., Tsoukas, C. M., Falutz, J., Lalonde, R., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/514696 · Cited by 69
Racemic Warfarin and Trimethoprim-Sulfamethoxazole Interaction in Humans
O’Reilly, R. A., & MOTLEY, C. H. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-1-34 · Cited by 66
Prophylaxis of Recurrent Acute Otitis Media and Middle-Ear Effusion
Principi, N. (1989) · American journal of diseases of children · doi:10.1001/archpedi.1989.02150240036013 · Cited by 66
Trimethoprim-Sulfamethoxazole in the Treatment of Bacteriuria in Women
Brumfitt, W., & Pursell, R. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_3.s657 · Cited by 54
Trimethoprim alters the disposition of procainamide and N-acetylprocainamide
Kosoglou, T., Rocci, M. L., & Vlasses, P. H. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.181 · Cited by 51
Bach, M. C., Finland, M., Gold, O. G., & Wilcox, C. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_3.s508 · Cited by 49
Increases in Rates of Resistance to Trimethoprim
Huovinen, P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s63 · Cited by 45
Acute psychoses associated with the use of ciprofloxacin and trimethoprim-sulfamethoxazole
McCue, J. D., & Zandt, J. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80097-6 · Cited by 44
Antineoplastic Agents Drug Interactions of Clinical Significance
van Meerten, E., Verweij, J., & Schellens, J. H. M. (1995) · Drug Safety · doi:10.2165/00002018-199512030-00003 · Cited by 41
The prophylaxis of bacterial infections in neutropenic patients
Kerr, K. G. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.5.587 · Cited by 41
Trimethoprim-Induced Hyperkalemia: An Analysis of Reported Cases
Marinella, M. A. (1999) · Gerontology · doi:10.1159/000022089 · Cited by 41
The Changing Pattern of Trimethoprim Resistance in Paris, with a Review of Worldwide Experience
Goldstein, F. W., Papadopoulou, B., & Acar, J. F. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.5.725 · Cited by 39
Gompels, M. M., Simpson, N. B., Snow, M., Spickett, G., & Ong, E. L. C. (1999) · Journal of Infection · doi:10.1016/s0163-4453(99)90078-6 · Cited by 37
Stein, D. S., Stevens, R. C., Terry, D., Laizure, S. C., Palte, S. B., Lancaster, D. J., Weems, J. J., & Williams, C. L. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1705 · Cited by 37
Symptomatic Hypoglycemia Secondary to a Glipizide—Trimethoprim/Sulfamethoxazole Drug Interaction
Johnson, J. F., & Dobmeier, M. E. (1990) · DICP · doi:10.1177/106002809002400307 · Cited by 31
Buskin, S. E., Newcomer, L. M., Koutsky, L. A., Hooton, T. M., Spach, D. H., & Hopkins, S. G. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199902010-00014 · Cited by 28
Limitations of and Indications for the Use of Co-trimoxazole
Brumfitt, W., & Hamilton-Miller, J. M. (1994) · Journal of Chemotherapy · doi:10.1080/1120009x.1994.11741120 · Cited by 22
Chemoprophylaxis of Recurrent Otitis Media Using Trimethoprim/Sulfamethoxazole
Gaskins, J. D., Holt, R. J., Kyong, C. U., Weart, C. W., & Ward, J. (1982) · Annals of Pharmacotherapy · doi:10.1177/106002808201600505 · Cited by 22
Bandrés, J. C., Mathewson, J. J., Ericsson, C. D., & DuPont, H. L. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199205000-00003 · Cited by 19
Aboulafia, D. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.598 · Cited by 16
Antimicrobial susceptibility of sixty human fecal isolates ofAeromonas species
Kuijper, E. J., Peeters, M. F., Schoenmakers, B. S. C., & Zanen, H. C. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01965270 · Cited by 15
Antibacterial Therapy for Acute Otitis Media: A Critical Analysis
Marchant, C. D., & Shurin, P. A. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.2.506 · Cited by 15
Boye, N. P., & Gaustad, P. (1991) · Infection · doi:10.1007/bf01715834 · Cited by 6
Cited by
Fate of antibiotics during municipal water recycling treatment processes
Le-Minh, N., Khan, S. J., Drewes, J. E., & Stuetz, R. M. (2010) · Water Research · doi:10.1016/j.watres.2010.06.020 · Cited by 778
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Catalysis and Sulfa Drug Resistance in Dihydropteroate Synthase
Yun, M.-K., Wu, Y., Li, Z., Zhao, Y., Waddell, M. B., Ferreira, A. M., Lee, R. E., Bashford, D., & White, S. W. (2012) · Science · doi:10.1126/science.1214641 · Cited by 260
Metadata
- Authors
- Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., & Joshi, N.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2003-02-24
- Volume
- 163
- Issue
- 4
- Pages
- 402
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2172073437
- Cited by
- 408
- References
- 83
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.